Zhanghuan Yang

Zhanghuan Yang

Auto-generated profile, based on publicly available information

Zhanghuan Yang

Department of Oncology, Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
ZYZhanghuan Yang
Zhanghuan Yang
HHHao He
Hao He
GHGuangxu He
Guangxu He
CZChudai Zeng
Chudai Zeng
QHQian Hu
Qian Hu
Background: Observational studies have suggested blood cell counts may act as predictors of cancer. It is not known whether these hematologic traits are causally associated with lung cancer.Methods: Two-sample bidirectional univariable Mendelian randomization (MR) and multivariable MR (MVMR) were performed to investigate the causal association between hematologic traits and the overall risk of lung cancer and three histologic subtypes [lung adenocarcinoma, squamous cell lung cancer, and small cell lung cancer (SCLC)]. The instrumental variables of 23 hematologic traits were strictly selected from large-scale genome-wide association studies. Inverse-variance weighted method and five extra methods were used to obtain robust causal estimates.Results: We found evidence that genetically influenced higher hematocrit [OR, 0.845; 95% confidence interval (CI), 0.783–0.913; P = 1.68 × 10−5] and hemoglobin concentration (OR, 0.868; 95% CI, 0.804–0.938; P = 3.20 × 10−4) and reticulocyte count (OR, 0.923; 95% CI, 0.872–0.976; P = 5.19 × 10−3) decreased lung carcinoma risk, especially in ever smokers. MVMR further identified hematocrit independently of smoking as an independent predictor. Subgroup analysis showed that a higher plateletcrit level increased the risk of small cell lung carcinoma (OR, 1.288; 95% CI, 1.126–1.474; P = 2.25 × 10−4).Conclusions: Genetically driven higher levels of reticulocyte count and hematocrit decreased lung cancer risk. Higher plateletcrit had an adverse effect on SCLC. Hematologic traits may act as low-cost factors for lung cancer risk stratification.Impact: Further studies are required to elucidate the potential mechanisms underlying the dysregulation of homeostasis related to hematologic traits, such as subclinical inflammation.

9 January 2024
Verified
Other
Open access
ZYZhanghuan Yang
Zhanghuan Yang
HHHao He
Hao He
GHGuangxu He
Guangxu He
CZChudai Zeng
Chudai Zeng
QHQian Hu
Qian Hu
SNPs Used in Multivariable Mendelian Randomization

9 January 2024
Verified
Other
Open access
ZYZhanghuan Yang
Zhanghuan Yang
HHHao He
Hao He
GHGuangxu He
Guangxu He
CZChudai Zeng
Chudai Zeng
QHQian Hu
Qian Hu
Causal Effects of Identified Traits in Lung Cancer in Ever/Never Smokers Estimated via Seven Methods for Each Association

9 January 2024
Verified
Other
Open access
ZYZhanghuan Yang
Zhanghuan Yang
HHHao He
Hao He
GHGuangxu He
Guangxu He
CZChudai Zeng
Chudai Zeng
QHQian Hu
Qian Hu
Leave-one-out plot for hematocrit on lung carcinoma.

9 January 2024
Verified
Other
Open access
ZYZhanghuan Yang
Zhanghuan Yang
HHHao He
Hao He
GHGuangxu He
Guangxu He
CZChudai Zeng
Chudai Zeng
QHQian Hu
Qian Hu
Causal effects of identified traits considering smoking and bilirubin. (a) Causal effects of 3 identified hematological traits and lung cancer in ever/never smokers. RAPS: Robust Adjusted Profile Score. (b) Effects of 3 identified hematological traits after adjustment for smoking. (c) Effects of 3 identified hematological traits after adjustment for bilirubin level.

9 January 2024
Verified
Other
Open access
ZYZhanghuan Yang
Zhanghuan Yang
HHHao He
Hao He
GHGuangxu He
Guangxu He
CZChudai Zeng
Chudai Zeng
QHQian Hu
Qian Hu
Description of Hematological Traits Evaluated in This MR Analysis